Polyoma BK virus: An emerging opportunistic infectious agent of the human central nervous system

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 3, 2011, Pages 276-284

  da Silva, Rodrigo Lopes ^a  

^a HOSPITAL DE SANTO ANTÓNIO DOS CAPUCHOS   (Portugal)

Author keywords

AIDS related opportunistic infections; BK virus; Bone marrow transplantation

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CIDOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BK VIRUS; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; NEUROIMAGING; NONHUMAN; OPPORTUNISTIC INFECTION; VIRUS INFECTION;

EID: 79959592840     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70189-1     Document Type: Article

References (48)

1. Reploeg MD, Storch GA, Clifford DB. BK virus: a clinical review. Clin Infect Dis. 2001; 33:191-202.
2. Hirsch HH.BK virus: opportunity makes a pathogen.Clin Infect Dis. 2005; 41:354-60.
3. Jiang M, Abend JR, Johnson SF, Imperiale MJ. The role of polyomaviruses in human disease. Virology 2009; 384:266-73.
4. Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol. 2010; 47:306-12.
5. Vago L, Cinque P, Sala E et al. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects.Study of 41 cases and review of the literature. J Acquir Immune Def Syndr Hum Retrovirol. 1996; 12:139-46.
6. Vallbracht A, Löhler J, Gossmann J et al. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol. 1993; 143:29-39.
7. Voltz R, Jäger G, Seelos K, Fuhry L, Hohlfeld R. BK virus encephalitis in an immunocompetent patient. Arch Neurol. 1996; 53:101-3.
8. Bratt G, Hammarin AL, Grandien M et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999; 13:1071-5.
9. Hedquist BG, Bratt G, Hammarin AL et al. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis.Ophthalmology 1999; 106:129-32.
10. Lesprit P, Chaline-Lehmann D, Authier FJ, Ponnelle T, Gray F, Levy Y. BK virus encephalitis in a patient with AIDS and lymphoma.AIDS 2001; 15:1196-9.
11. Stoner GL, Alappan R, Jobes DV, Ryschkewitsch CF, Landry ML. BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis. Am J Kidney Dis. 2002; 39:1102-12.
12. Garavelli PL, Boldorini R. BK virus encephalitis in an HIV-seropositive patient. Preliminary data. Recenti Prog Med. 2002; 93:247.
13. Jørgensen GE, Hammarin AL, Bratt G, Grandien M, Flaegstad T, Johnsen JI. Identification of a unique BK virus variant in the CNS of a patient with AIDS.J Med Virol. 2003; 70:14-9.
14. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM, Bonington A BKV DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis.Infection 2003; 31:374-8.
15. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM.BK virus DNA in CSF of immunocompetent and immunocompromised patients. Arch Dis Child 2003; 88:174-5.
16. Hix JK, Braun WE, Isada CM. Delirium in a renal transplant recipient associated with BK virus in the cerebrospinal fluid. Transplantation 2004; 78:1407-8.
17. Cabrejo L, Diop M, Blohorn-Sense A, Mihout B. Progressive BK virus associated multifocal leukoencephalopathy in an immunocompromised patient treated with corticosteroids. Revue Neurologique 2005;161:326-30.
18. Friedman DP, Flanders AE. MR Imaging of BK virus encephalitis. AJNR Am J Neuroradiol. 2006; 27:1016-8.
19. Vidal JE, Fink MC, Cedeno-Laurent F et al. BK virus associated Meningoencephalitis in na AIDS patient treated with HAART. AIDS Res Therapy 2007; 4:13.
20. Ferrari A, Luppi M, Marasca R et al. BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab. Eur J Haematol. 2008; 81:244-5.
21. Behre G, Becker M, Christopeit M. BK virus encephalitis in an allogeneic hematopoietic stem cell recipient.Bone Marrow Transplant. 2008; 42:499.
22. Kinnaird AN, Anstead GM. Hemorrhagic cystitis and possible neurologic disease from BK virus infection in a patient with AIDS. Infection 2010; 38:124-7.
23. Lopes da Silva R, Ferreira I, Teixeira G et al. BK virus encephalitis with thrombotic microangiopathy in an allogeneic hematopoietic stem cell transplant recipient. Transpl Infect Dis. 2010;13:161-7.
24. Moret H, Guichard M, Matheron S et al. Virologic diagnosis of progressive multifocal leukoencephalopathy: detection of JC Virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol. 1993; 31:3310-3.
25. De Mattei M, Martini F, Tognon M et al. Polyomavirus latency and human tumors. J Infect Dis. 1994; 169:1175-6.
26. De Mattei M, Martini F, Corallini A et al. High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. Int J Cancer 1995; 61:756-60.
27. Elsner C, Dorries K. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 1992; 191:72-80.
28. Dorries K. Molecular biology and pathogenesis of human polyomavirus infections. Dev Biol Stand. 1998; 94:71-9.
29. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis. 1983; 147:676-84.
30. White FA III, Ishaq M, Stoner GL et al. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol. 1992; 66:5726-34.
31. Ferrante P, Caldarelli-Stefano R, Omodeo-Zorini E et al. PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy. J Med Virol. 1995; 47:219-25.
32. Perrons CJ, Fox JD, Lucas SB et al. Detection of polyomaviral DNA in clinical samples from immunocompromised patients: correlation with clinical disease. J Infect. 1996; 32:205-9.
33. Dorries K, Vogel E, Gunther S et al. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994; 198:59-70.
34. Sundsfjord A, Flaegstad T, Flo R et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis. 1994; 169:485-90.
35. De Santis R, Azzi A. Duplex polymerase chain reaction for the simultaneous detection of the human polyomavirus BK and JC DNA. Mol Cell Probes 1996; 10:325-30.
36. Hanssen Rinaldo C, Hansen H, Traavik T. Human endothelial cells allow passage of an archetypal BK virus (BKV) strain-a tool for cultivation and functional studies of natural BKV strains. Arch Virol. 2005; 150:1449-58.
37. Siegert W. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26:347-50.
38. González-Fraile MI, Cañizo C, Caballero D et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl. Infect Dis. 2001; 3:44-46.
39. Barouch DH, Faquin WC, Chen Y, Koralnik IJ, Robbins GK, Davis BT. BK virus-associated hemorrhagic cystitis in a human immunodeficiency virus-infected patient. Clin Infect Dis. 2002; 35:326-9.
40. Ganguly N, Clough LA, Dubois LK et al. Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. Transpl Infect Dis. 2010; 12:406-11.
41. Pallet N, Burgard M, Quamouss O et al. Cidofovir may be deleterious in BK virus-associated nephropathy. Transplantation 2010; 89:1542-4.
42. Wu JK, Harris MT. Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy.Ann Pharmacother. 2008; 42:1679-85.
43. Araya CE, Garin EH, Neiberger RE, Dharnidharka VR. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients. Pediatr Transplant. 2010; 14:145-50.
44. Leung AY, Chan MT, Yuen KY et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2005; 40:528-37.
45. Koukoulaki M, Apostolou T, Hadjiconstantinou V, Drakopoulos S. Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication.Transpl Infect Dis. 2008; 10(6):449-51.
46. Gabardi S, Waikar SS, Martin S et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010; 5:1298-304
47. Randhawa PS, Farasati NA, Huang Y, Mapara MY, Shapiro R. Viral drug sensitivity testing using quantitative PCR: effect of tyrosine kinase inhibitors on polyomavirus BK replication. Am J Clin Pathol. 2010; 134:916-20.
48. Dropulic LK, Cohen JI. Update on new antivirals under development for the treatment of double-stranded DNA virus infections. Clin Pharmacol Ther. 2010; 88:610-9.